HCPCS Level IIdrugActive
J1327
Eptifibatide injection
BETOS: O1E
Effective: 2024-01-01
Description
Injection, eptifibatide, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Eptifibatide
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
5 MG
Billing Units
15.0000
21
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.